Business
Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments
Dallas, Texas, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of men’s wellness products via a secure telemedicine platform under the brand MangoRx, proudly announces the official launch of PeachesRx, an innovative women’s health and wellness brand focused on providing cutting-edge, convenient treatments tailored to women’s unique health needs. These new and innovative wo
About this update from Mangoceuticals, Inc.
[{"type":"image","alt":"Mangoceuticals, Inc.","displaySize":"","headline":null,"caption":"Mangoceuticals, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":169,"url":"https://media.zenfs.com/en/globenewswire.com/bdaa76f41fbcee768a28b368165d8594"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yc_MqNhcKnFfb6ybGyCwLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIzNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/bdaa76f41fbcee768a28b368165d8594","width":300,"height":169}},"lazy":false},{"type":"text","content":"Dallas, Texas, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of men’s wellness products via a secure telemedicine platform under the brand MangoRx, proudly announces the official launch of PeachesRx, an innovative women’s health and wellness brand focused on providing cutting-edge, convenient treatments tailored to women’s unique health needs. These new and innovative women’s health and wellness products will be made available via a secure telemedicine platform located at www.PeachesRx.com.","length":642,"tagName":"p"},{"type":"text","content":"PeachesRx will debut with a strong focus on compounded GLP-1 receptor agonists—a class of medications proven to aid weight loss by regulating appetite and glucose metabolism. Recent studies show that approximately 70% of GLP-1 prescriptions for weight loss are written for women, reflecting their dominant role in driving the surge in demand for these medications. By introducing its tailored GLP-1 offerings, PeachesRx aims to meet the unique metabolic needs of women while providing an accessible and affordable telehealth-driven solution.","length":541,"tagName":"p"},{"type":"text","content":"Market demand for GLP-1 weight loss treatments among women is expanding rapidly. Industry projections estimate that the global GLP-1 market for weight management will exceed $48 billion by 2030, with women comprising the majority of users. Additionally, the global women’s health market was valued at $49.33 billion in 2024 and is projected to reach $68.53 billion by 2030, growing at a 5.1% CAGR. Within the U.S. women's telehealth market, growth is fueled by increased awareness, the demand for remote care, and the rise of personalized ...